These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 2128454)

  • 21. RNase inhibition of human immunodeficiency virus infection of H9 cells.
    Youle RJ; Wu YN; Mikulski SM; Shogen K; Hamilton RS; Newton D; D'Alessio G; Gravell M
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6012-6. PubMed ID: 8016107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety, activity, and pharmacokinetics of GLQ223 in patients with AIDS and AIDS-related complex.
    Kahn JO; Gorelick KJ; Gatti G; Arri CJ; Lifson JD; Gambertoglio JG; Bostrom A; Williams R
    Antimicrob Agents Chemother; 1994 Feb; 38(2):260-7. PubMed ID: 7910722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of two new N-glycosidase type-1 ribosome-inactivating proteins, unrelated in amino-acid sequence, from Petrocoptis species.
    Arias FJ; Rojo MA; Ferreras JM; Iglesias R; Muñoz R; Soriano F; Méndez E; Barbieri L; Girbés T
    Planta; 1994; 194(4):487-91. PubMed ID: 7528586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiretroviral therapy: strategies beyond single-agent reverse transcriptase inhibition.
    Connolly KJ; Hammer SM
    Antimicrob Agents Chemother; 1992 Mar; 36(3):509-20. PubMed ID: 1377897
    [No Abstract]   [Full Text] [Related]  

  • 25. Targeted kill: from umbrellas to monoclonal antibodies.
    Byers VS; Baldwin RW
    J Clin Immunol; 1992 Nov; 12(6):391-405. PubMed ID: 1287032
    [No Abstract]   [Full Text] [Related]  

  • 26. A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents.
    Byers VS; Levin AS; Malvino A; Waites L; Robins RA; Baldwin RW
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):413-20. PubMed ID: 7915124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichosanthin treatment of HIV-induced immune dysregulation.
    Mayer RA; Sergios PA; Coonan K; O'Brien L
    Eur J Clin Invest; 1992 Feb; 22(2):113-22. PubMed ID: 1572389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and pharmacokinetics of GLQ223 in subjects with AIDS and AIDS-related complex: a phase I study.
    Kahn JO; Kaplan LD; Gambertoglio JG; Bredesen D; Arri CJ; Turin L; Kibort T; Williams RL; Lifson JD; Volberding PA
    AIDS; 1990 Dec; 4(12):1197-204. PubMed ID: 2088398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transient elevation of serum HIV antigen levels associated with intercurrent infection.
    Claydon EJ; Bennett J; Gor D; Forster SM
    AIDS; 1991 Jan; 5(1):113-4. PubMed ID: 1905552
    [No Abstract]   [Full Text] [Related]  

  • 30. A phase I/II trial of zidovudine, interferon-alpha, and granulocyte-macrophage colony-stimulating factor in the treatment of human immunodeficiency virus type 1 infection.
    Davey RT; Davey VJ; Metcalf JA; Zurlo JJ; Kovacs JA; Falloon J; Polis MA; Zunich KM; Masur H; Lane HC
    J Infect Dis; 1991 Jul; 164(1):43-52. PubMed ID: 1676045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and tolerance of dideoxycytidine as a single agent. Results of early-phase studies in patients with acquired immunodeficiency syndrome (AIDS) or advanced AIDS-related complex. Study Group of the AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases.
    Merigan TC; Skowron G
    Am J Med; 1990 May; 88(5B):11S-15S. PubMed ID: 2159703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A phase I/II study of trichosanthin treatment of HIV disease.
    Byers VS; Levin AS; Waites LA; Starrett BA; Mayer RA; Clegg JA; Price MR; Robins RA; Delaney M; Baldwin RW
    AIDS; 1990 Dec; 4(12):1189-96. PubMed ID: 2128454
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.